BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $54 | $3 | $72 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $14 | $55 | $3 | $73 |
| Property Plant & Equip (Net) | $13 | $44 | $14 | $42 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $13 | $45 | $14 | $43 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $27 | $100 | $18 | $116 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $1 | $17 |
| Short-Term Debt | $0 | $1 | $19 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $3 | $0 | $1 |
| Total Curr. Liab. | $2 | $7 | $20 | $19 |
| LT Debt | $21 | $69 | $2 | $131 |
| Deferred Rev, NC | $0 | $0 | $0 | $15 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $2 |
| Other NC Liab. | $5 | $0 | $0 | $15 |
| Total NC Liab. | $26 | $69 | $2 | $162 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $29 | $76 | $22 | $181 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$116 | -$365 | -$101 | -$320 |
| AOCI | -$2 | $0 | $0 | $0 |
| Other Equity | $116 | $388 | $96 | $255 |
| Total Equity | -$2 | $23 | -$5 | -$65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $27 | $100 | $18 | $116 |
| Net Debt | $7 | $16 | $18 | $59 |